Cargando…

Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using (11)C-ITMM positron emission tomography

Imaging of type 1 metabotropic glutamate receptor (mGluR1) has recently become possible using positron emission tomography (PET). To date, little evidence exists on the role of mGluR1 in the pathophysiology of Alzheimer's disease (AD). We aimed to examine mGluR1 availability in patients with AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishibashi, Kenji, Miura, Yoshiharu, Toyohara, Jun, Ishiwata, Kiichi, Ishii, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434168/ https://www.ncbi.nlm.nih.gov/pubmed/30909027 http://dx.doi.org/10.1016/j.nicl.2019.101783

Ejemplares similares

Adenosine A(2A) Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2020)

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using (18)F-THK5351 positron emission tomography
por: Ishibashi, Kenji, et al.
Publicado: (2020)

Binding of Pramipexole to Extrastriatal Dopamine D(2)/D(3) Receptors in the Human Brain: A Positron Emission Tomography Study Using (11)C-FLB 457
por: Ishibashi, Kenji, et al.
Publicado: (2011)

Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects
por: Ishikawa, Masatomo, et al.
Publicado: (2011)

Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [(11)C]CB184, in healthy human volunteers
por: Sakata, Muneyuki, et al.
Publicado: (2017)

PET Imaging of (18)F-FDG, (11)C-methionine, (11)C-flumazenil, and (11)C-4DST in Progressive Multifocal Leukoencephalopathy
por: Ishibashi, Kenji, et al.
Publicado: (2017)

Improved Visualization and Specific Binding for Metabotropic Glutamate Receptor Subtype 1 (mGluR1) Using [(11)C]ITMM with Ultra-High Specific Activity in Small-Animal PET
por: Yamasaki, Tomoteru, et al.
Publicado: (2015)

Synthesis and evaluation of N-isopropyl-p-[(11)C]methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography
por: Toyohara, Jun, et al.
Publicado: (2020)

In Vivo Evaluation of (11)C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain
por: Zhang, Ji-chun, et al.
Publicado: (2012)

Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson’s disease and multiple system atrophy: a case report
por: Ishibashi, Kenji, et al.
Publicado: (2015)

Age-Related Decrease in Male Extra-Striatal Adenosine A(1) Receptors Measured Using (11)C-MPDX PET
por: Mishina, Masahiro, et al.
Publicado: (2017)

(11)C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains
por: Zanotti-Fregonara, Paolo, et al.
Publicado: (2013)

Localization of metabotropic glutamate receptors in the outer plexiform layer of the goldfish retina
por: Joselevitch, Christina, et al.
Publicado: (2007)

In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [(11)C]A-582941 and [(11)C]A-844606 in Mice and Conscious Monkeys
por: Toyohara, Jun, et al.
Publicado: (2010)

Metabolic Network Topology of Alzheimer’s Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography
por: Imai, Masamichi, et al.
Publicado: (2020)

Effects of glucose, insulin, and insulin resistance on cerebral (18)F-FDG distribution in cognitively normal older subjects
por: Ishibashi, Kenji, et al.
Publicado: (2017)

Changes in cerebral blood flow during steady-state cycling exercise: a study using oxygen-15-labeled water with PET
por: Hiura, Mikio, et al.
Publicado: (2014)

Longitudinal effects of aging on (18)F-FDG distribution in cognitively normal elderly individuals
por: Ishibashi, Kenji, et al.
Publicado: (2018)

Usefulness of (11)C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report
por: Nakano, Tomoyuki, et al.
Publicado: (2018)

Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study
por: Zimmermann, Maria, et al.
Publicado: (2022)

Synthesis and evaluation of [(11)C]MMPIP as a potential radioligand for imaging of metabotropic glutamate 7 receptor in the brain
por: Yamasaki, Tomoteru, et al.
Publicado: (2013)

The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies
por: Terbeck, Sylvia, et al.
Publicado: (2015)

Radiosynthesis and Evaluation of an (18)F-Labeled Positron Emission Tomography (PET) Radioligand for Metabotropic Glutamate Receptor Subtype 4 (mGlu(4))
por: Kil, Kun-Eek, et al.
Publicado: (2014)

Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity
por: Kawakubo, Yuki, et al.
Publicado: (2011)

Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)

Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013)

Kinetic fingerprinting of metabotropic glutamate receptors
por: Kukaj, Taulant, et al.
Publicado: (2023)

Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia
por: Kubota, Manabu, et al.
Publicado: (2022)

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022)

Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks
por: Dupont, Anne-Claire, et al.
Publicado: (2023)

Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans
por: Smart, Kelly, et al.
Publicado: (2021)

Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [(11)C]ABP688 Positron-Emission Tomography (PET) Imaging
por: DuBois, Jonathan M., et al.
Publicado: (2016)

Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)
por: Egerton, Alice, et al.
Publicado: (2020)

Test-retest variability of adenosine A(2A) binding in the human brain with (11)C-TMSX and PET
por: Naganawa, Mika, et al.
Publicado: (2014)

Therapeutic promise and principles: Metabotropic glutamate receptors
por: Maiese, Kenneth, et al.
Publicado: (2008)

Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
por: Hovelsø, N, et al.
Publicado: (2012)

Homology modelling of metabotropic glutamate receptor 2
por: Mordalski, S, et al.
Publicado: (2011)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

Constitutive activity of metabotropic glutamate receptor 7
por: Kammermeier, Paul J
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jhe826qm03na7e04m9r595a4qa